PMD Healthcare Announces Two New Patient Advisory Boards

PMD Healthcare, a medical device, digital health and chronic care management services company, has announced it is forming two new patient advisory boards: one for Cystic Fibrosis (CF) patients and caregivers of CF Children, and one for Pulmonary Fibrosis (PF) patients and PF caregivers.

The purpose and charter for these two patient advisory boards is to obtain information and opinions directly from patients and caregivers to better understand their needs, challenges and issues pertaining to managing their daily care plans. PMD Healthcare will also share healthcare industry information and regulations to better inform patients of the changes happening that could affect their lives, and get their feedback and perspectives concerning new healthcare regulations, insurer/payer issues and care management recommendations.

Both the Cystic Fibrosis and the Pulmonary Fibrosis Boards will meet bi-monthly via online video conferencing with the meeting running for approximately one hour. Participants will be compensated for their time and will be given the opportunity to become “thought leaders” by sharing their views in blogs, videos, podcasts and social media sites.

“Working directly with CF and PF patients and their caregivers will enable us to better understand, and meet the needs of, patients in terms of education, new product development and support services,” said Steve Sullivan, PMD Healthcare’s EVP and Chief Commercial Officer.

PMD Healthcare is currently recruiting patients and caregivers for both boards and anticipates the first board meetings to occur in February and March 2018. For more information about the PF advisory board visit For more information about the CF advisory board visit


Founded in 2010, PMD Healthcare specializes in medical devices, digital health, and chronic care management and is dedicated to creating innovative solutions that empower people to improve their healthcare and quality of life. PMD Healthcare developed the first personal spirometer, Spiro PD, approved by the FDA in 2011. PMD is currently launching several new remote monitoring products, including its second-generation spirometer, Spiro PD 2.0, and its HIPPA-compliant Wellness Management System (WMS). To learn more, visit




Leave a Reply

Your email address will not be published. Required fields are marked *